Brief: Imugene And Kincell Bio Announce Strategic Partnership
April 16 (Reuters) - Imugene Ltd IMU.AX :
* IMUGENE AND KINCELL BIO ANNOUNCE STRATEGIC PARTNERSHIP
* AS A RESULT OF TRANSFER, IMUGENE WILL RECOGNIZE $32M USD
IN
STAFF COST REDUCTIONS, AMONG OTHERS OVER NEXT THREE YEARS
* STRATEGIC MANUFACTURING AND PROCESS DEVELOPMENT
PARTNERSHIP WILL
SUPPORT IMUGENE'S AZER-CEL CLINICAL STUDY SUPPLY
* WILL ALSO TRANSFER PROCESS AND ANALYTICAL DEVELOPMENT OF
AZER-CEL TO KINCELL
Further company coverage: IMU.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imugene
See all newsAustralia's Imugene rises on fresh responses in blood cancer drug trial
Brief: Imugene Ltd Says Leslie Chong Resigns As CEO
Australia's Imugene loses most in over 8-years on discounted placement
Brief: Imugene To Raise A$11.12 Million Via Placement At A$0.095 Per Share
Brief: Imugene Requests Trading Halt Pending Proposed Capital Raising Announcement